Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the ARV-471 study is available, with detailed study and participant information, outcome measures, record dates, and study documents. The record indicates the study is completed and is no longer recruiting participants.
    Difference
    100%
    Check dated 2026-11-08T15:49:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the study record page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T16:42:26.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record itself is still unavailable.
    Difference
    1%
    Check dated 2026-10-25T17:08:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T21:57:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T20:57:28.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record. This reflects an access-state issue rather than a content update to the study details or related information.
    Difference
    20%
    Check dated 2026-09-20T20:35:57.000Z thumbnail image

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.